You have 9 free searches left this month | for more free features.

Z 338

Showing 1 - 25 of 1,025

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Functional Dyspepsia Trial in Matsumoto (Acotiamide HCl hydrate, Placebo)

Recruiting
  • Functional Dyspepsia
  • Acotiamide hydrochloride hydrate
  • Placebo
  • Matsumoto, Nagano, Japan
    Zeria Investigative Site
Mar 23, 2021

General Anesthesia Trial in Zhengzhou (Etomidate, Propofol)

Recruiting
  • General Anesthesia
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Feb 3, 2022

Hyperkalemia Trial in Worldwide (Patiromer)

Terminated
  • Hyperkalemia
  • Palo Alto, California
  • +29 more
Oct 17, 2022

Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Crovalimab)

Recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Hollywood, Florida
  • +25 more
Aug 23, 2022

Hypophosphatasia Trial in Worldwide (ALXN1850, Placebo)

Not yet recruiting
  • Hypophosphatasia
  • Indianapolis, Indiana
  • +90 more
Oct 6, 2023

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting
  • Neoplasms
  • Augusta, Georgia
  • +77 more
Nov 8, 2022

Anemia, Renal Insufficiency, Chronic Trial in Worldwide (Mircera)

Completed
  • Anemia
  • Renal Insufficiency, Chronic
  • Birmingham, Alabama
  • +21 more
Mar 3, 2022

Extensive-stage Small Cell Lung Cancer Trial in Worldwide (BMS-986012, Carboplatin, Etoposide)

Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • BMS-986012
  • +3 more
  • Birmingham, Alabama
  • +42 more
Apr 30, 2022

Contrast Enhancement in Magnetic Resonance Imaging, Children Trial in Worldwide (Gadoquatrane (BAY1747846))

Not yet recruiting
  • Contrast Enhancement in Magnetic Resonance Imaging
  • Children
  • Gadoquatrane (BAY1747846)
  • Indian Wells, California
  • +43 more
Jun 14, 2023

Allergy Trial in Worldwide (SQ tree SLIT-tablet, Placebo)

Recruiting
  • Allergy
  • SQ tree SLIT-tablet
  • Placebo
  • Vienna, Austria
  • +83 more
Dec 21, 2022

Irritable Bowel Syndrome Trial in Worldwide (Eluxadoline, Placebo)

Recruiting
  • Irritable Bowel Syndrome
  • Hot Springs, Arkansas
  • +50 more
Jun 27, 2022

Postmenopausal Osteoporosis Trial in Worldwide (RGB-14-P, Prolia®)

Recruiting
  • Postmenopausal Osteoporosis
  • Miami Lakes, Florida
  • +57 more
Feb 22, 2022

Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Crovalimab)

Recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Orange, California
  • +63 more
Jan 9, 2023

Chronic Hand Eczema Trial in Worldwide (Delgocitinib, Toctino)

Recruiting
  • Chronic Hand Eczema
  • Graz, Austria
  • +46 more
Jul 15, 2022

Psoriasis Trial in Worldwide (Ustekinumab, ABP 654)

Active, not recruiting
  • Psoriasis
  • Hot Springs, Arkansas
  • +87 more
Nov 4, 2022

Severe Hypertriglyceridemia Trial in Worldwide (Olezarsen, Placebo)

Recruiting
  • Severe Hypertriglyceridemia
  • Chula Vista, California
  • +109 more
Jan 23, 2023

Postmenopausal Osteoporosis Trial in Worldwide (FKS518, US-licensed Prolia)

Active, not recruiting
  • Postmenopausal Osteoporosis
  • Sofia, Sofia City, Bulgaria
  • +75 more
Aug 29, 2022

Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Placebo, Obicetrapib)

Recruiting
  • Dyslipidemias
  • +4 more
  • Anniston, Alabama
  • +126 more
Dec 8, 2022

Episodic Migraine Trial in Worldwide (Atogepant 60 mg, Placebo)

Completed
  • Episodic Migraine
  • Atogepant 60 mg
  • Placebo
  • Colton, California
  • +113 more
Aug 12, 2022

Rheumatoid Arthritis Trial in Worldwide (PF-06650833, PF-06651600, Tofacitinib)

Completed
  • Rheumatoid Arthritis
  • Pleven, Bulgaria
  • +143 more
Mar 2, 2022

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Obesity Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +106 more
Jan 24, 2023

Endogenous Cushing's Syndrome Trial in Worldwide (Levoketoconazole)

Completed
  • Endogenous Cushing's Syndrome
  • Los Angeles, California
  • +41 more
Mar 22, 2021